- Home
- TRST vs PHAR Comparison
TRST vs PHAR Comparison
Compare TRST & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRST
- PHAR
- Stock Information
- Founded
- TRST 1902
- PHAR 1988
- Country
- TRST United States
- PHAR Netherlands
- Employees
- TRST N/A
- PHAR N/A
- Industry
- TRST Major Banks
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- TRST Finance
- PHAR Health Care
- Exchange
- TRST Nasdaq
- PHAR Nasdaq
- Market Cap
- TRST 540.7M
- PHAR 718.1M
- IPO Year
- TRST N/A
- PHAR N/A
- Fundamental
- Price
- TRST $33.28
- PHAR $11.00
- Analyst Decision
- TRST
- PHAR Strong Buy
- Analyst Count
- TRST 0
- PHAR 3
- Target Price
- TRST N/A
- PHAR $30.00
- AVG Volume (30 Days)
- TRST 103.4K
- PHAR 3.0K
- Earning Date
- TRST 07-21-2025
- PHAR 07-31-2025
- Dividend Yield
- TRST 4.32%
- PHAR N/A
- EPS Growth
- TRST N/A
- PHAR N/A
- EPS
- TRST 2.68
- PHAR N/A
- Revenue
- TRST $173,999,000.00
- PHAR $320,708,000.00
- Revenue This Year
- TRST $13.13
- PHAR $13.31
- Revenue Next Year
- TRST N/A
- PHAR $7.68
- P/E Ratio
- TRST $12.44
- PHAR N/A
- Revenue Growth
- TRST N/A
- PHAR 24.13
- 52 Week Low
- TRST $27.18
- PHAR $6.65
- 52 Week High
- TRST $38.89
- PHAR $12.61
- Technical
- Relative Strength Index (RSI)
- TRST 66.02
- PHAR 51.11
- Support Level
- TRST $30.52
- PHAR $10.23
- Resistance Level
- TRST $32.53
- PHAR $11.21
- Average True Range (ATR)
- TRST 0.67
- PHAR 0.27
- MACD
- TRST 0.13
- PHAR -0.14
- Stochastic Oscillator
- TRST 99.03
- PHAR 34.01
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.